167 related articles for article (PubMed ID: 9758100)
1. Equine TIMP-1 and TIMP-2: identification, activity and cellular sources.
Clegg PD; Coughlan AR; Carter SD
Equine Vet J; 1998 Sep; 30(5):416-23. PubMed ID: 9758100
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of equine matrix metalloproteinase 2 and 9; and identification of the cellular sources of these enzymes in joints.
Clegg PD; Burke RM; Coughlan AR; Riggs CM; Carter SD
Equine Vet J; 1997 Sep; 29(5):335-42. PubMed ID: 9306058
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases 2 and 9 in equine synovial fluids.
Clegg PD; Coughlan AR; Riggs CM; Carter SD
Equine Vet J; 1997 Sep; 29(5):343-8. PubMed ID: 9306059
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
5. Determination of MMP-2 and -9 activities in synovial fluid of horses with osteoarthritic and arthritic joint diseases using gelatin zymography and immunocapture activity assays.
Fietz S; Einspanier R; Hoppner S; Hertsch B; Bondzio A
Equine Vet J; 2008 May; 40(3):266-71. PubMed ID: 18089467
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-2 and -9 are activated in joint diseases.
Clegg PD; Carter SD
Equine Vet J; 1999 Jul; 31(4):324-30. PubMed ID: 10454092
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints.
Takei I; Takagi M; Santavirta S; Ida H; Hamasaki M; Ishii M; Fukushima S; Ogino T; Konttinen YT
J Biomed Mater Res; 1999 Jun; 45(3):175-83. PubMed ID: 10397973
[TBL] [Abstract][Full Text] [Related]
8. Synovial fluid gelatinase concentrations and matrix metalloproteinase and cytokine expression in naturally occurring joint disease in horses.
Trumble TN; Trotter GW; Oxford JR; McIlwraith CW; Cammarata S; Goodnight JL; Billinghurst RC; Frisbie DD
Am J Vet Res; 2001 Sep; 62(9):1467-77. PubMed ID: 11560279
[TBL] [Abstract][Full Text] [Related]
9. Canine TIMP-2: purification, characterization and molecular detection.
Bee A; Barnes A; Jones MD; Robertson DH; Clegg PD; Carter SD
Vet J; 2000 Sep; 160(2):126-34. PubMed ID: 10985804
[TBL] [Abstract][Full Text] [Related]
10. Metalloproteinases and tumor necrosis factor-alpha activities in synovial fluids of horses: correlation with articular cartilage alterations.
Jouglin M; Robert C; Valette JP; Gavard F; Quintin-Colonna F; Denoix JM
Vet Res; 2000; 31(5):507-15. PubMed ID: 11050746
[TBL] [Abstract][Full Text] [Related]
11. Batimastat (BB-94) inhibits matrix metalloproteinases of equine laminitis.
Pollitt CC; Pass MA; Pollitt S
Equine Vet J Suppl; 1998 Sep; (26):119-24. PubMed ID: 9932102
[TBL] [Abstract][Full Text] [Related]
12. Identification of tissue inhibitor of metalloproteinase-2 (TIMP-2)-progelatinase complex as the third metalloproteinase inhibitor peak in rheumatoid synovial fluid.
Cawston TE; Bigg HF; Clark IM; Hazleman BL
Ann Rheum Dis; 1993 Mar; 52(3):177-81. PubMed ID: 8484669
[TBL] [Abstract][Full Text] [Related]
13. Epithelial and bacterial metalloproteinases and their inhibitors in H. pylori infection of human gastric cells.
Göõz M; Göõz P; Smolka AJ
Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G823-32. PubMed ID: 11518695
[TBL] [Abstract][Full Text] [Related]
14. Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis.
Blaser J; Triebel S; Maasjosthusmann U; Romisch J; Krahl-Mateblowski U; Freudenberg W; Fricke R; Tschesche H
Clin Chim Acta; 1996 Jan; 244(1):17-33. PubMed ID: 8919199
[TBL] [Abstract][Full Text] [Related]
15. Red blood cells increase secretion of matrix metalloproteinases from human lung fibroblasts in vitro.
Fredriksson K; Liu XD; Lundahl J; Klominek J; Rennard SI; Skold CM
Am J Physiol Lung Cell Mol Physiol; 2006 Feb; 290(2):L326-33. PubMed ID: 16403942
[TBL] [Abstract][Full Text] [Related]
16. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
Goldbach-Mansky R; Lee JM; Hoxworth JM; Smith D; Duray P; Schumacher RH; Yarboro CH; Klippel J; Kleiner D; El-Gabalawy HS
Arthritis Res; 2000; 2(2):145-53. PubMed ID: 11062605
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human subconjunctival tissues.
Kawashima Y; Saika S; Yamanaka O; Okada Y; Ohkawa K; Ohnishi Y
Curr Eye Res; 1998 Apr; 17(4):445-51. PubMed ID: 9561837
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases in mild and severe temporomandibular joint internal derangement synovial fluid.
Srinivas R; Sorsa T; Tjäderhane L; Niemi E; Raustia A; Pernu H; Teronen O; Salo T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):517-25. PubMed ID: 11346728
[TBL] [Abstract][Full Text] [Related]
19. Secretion of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases into follicular fluid during follicle development in equine ovaries.
Riley SC; Gibson AH; Leask R; Mauchline DJ; Pedersen HG; Watson ED
Reproduction; 2001 Apr; 121(4):553-60. PubMed ID: 11277874
[TBL] [Abstract][Full Text] [Related]
20. Localization of MMP-2, MMP-9, TIMP-1, and TIMP-2 in human coronal dentine.
Niu LN; Zhang L; Jiao K; Li F; Ding YX; Wang DY; Wang MQ; Tay FR; Chen JH
J Dent; 2011 Aug; 39(8):536-42. PubMed ID: 21641958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
